| SpectraBase Spectrum ID |
8HUBPsl7V3I |
| Name |
Methylaminorex para methyl |
| Classification |
Phenethylamine designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| DEA Citation |
21 CFR §1308.11 (f) (5) |
| DEA Controlled Substance Name |
4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine |
| DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
| DEA Controlled Substances Code Number |
1595 |
| DEA Schedule |
Schedule I |
| DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers. |
| Exact Mass |
190.110613078 u |
| Formula |
C11H14N2O |
| InChI |
InChI=1S/C11H14N2O/c1-7-3-5-9(6-4-7)10-8(2)13-11(12)14-10/h3-6,8,10H,1-2H3,(H2,12,13) |
| InChIKey |
NPILLHMQNMXXTL-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
190.246 g/mol |
| Nominal Mass |
190 u |
| Quality |
990 |
| Retention Index |
1686 |
| SMILES |
NC=1OC(C=2C=CC(=CC2)C)C(N1)C |
| SPLASH |
splash10-00xv-9600000000-4f79b108395141d16924 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
4,4'-DMAR
4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-ylazan
4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_017039 |
